Up Next
Back to Show
Aging Matters
How Gene Therapy Could Change Vision Loss
At 88, Anette McRay faced fading vision from age-related macular degeneration and endured constant eye injections to slow her vision loss. But after she joined an experimental gene therapy trial at Vanderbilt Eye Institute, her sight, as well as her independence, is being preserved, offering hope for millions facing the same devastating disease.
Support Provided By
26:46
The cost of long-term care and burden of providing it have led to a crisis for seniors.
27:58
This edition of Aging Matters focuses on health disparities among older adults.
28:21
This NPT original explores the benefits/challenges of developing relationships as we age.
28:32
NPT Reports Aging Matters: Opioids & Addiction explores the painful story of addiction.
28:24
A look at the risks of hospital treatment as we age and how some hospitals are adapting.
29:41
NPT explores how growing older can be an isolating experience for our aging community.